The trial investigated the effectiveness of ICP interventions for LC. The intervention arms were (i) multi-organ magnetic resonance imaging (MRI; Coverscan), (ii) digital rehabilitation (Living with COVID Recovery), (iii) both multi-organ MRI and digital rehabilitation, and (iv) neither multi-organ MRI nor digital rehabilitation (usual care). Overall, the primary outcome was achieved in all arms, with scores improving by 4.5 points to 31.3 (s.d. 9.31) at 12 weeks. Compared with usual care, effects on 12-week FAS were −0.18 (95% confidence interval −0.72, 1.09; P = 0.69) with multi-organ MRI; −0.53 (−1.42, 0.36; P = 0.25) with digital rehabilitation; and −0.17 (−1.06, 0.72; P = 0.71) with their interaction.
Read more on the Nature Medicine website.